WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

The Procter & Gamble Company vs Sanofi

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

The Procter & Gamble Company

PG · New York Stock Exchange

Market cap (USD)$390.8B
Gross margin (TTM)49.8%
Operating margin (TTM)22.6%
Net margin (TTM)18.2%
SectorConsumer
IndustryHousehold and personal products
CountryUS
Data as of2026-08-23
85/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into The Procter & Gamble Company's moat claims, evidence, and risks.

View PG analysis

Sanofi

SAN · Euronext Paris

Market cap (USD)$115.7B
Gross margin (TTM)73.4%
Operating margin (TTM)12.7%
Net margin (TTM)8.1%
SectorHealthcare
IndustryPharmaceuticals
CountryFR
Data as of2026-08-23
66/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Sanofi's moat claims, evidence, and risks.

View SAN analysis

Comparison highlights

  • Moat score gap: The Procter & Gamble Company leads (85 / 100 vs 66 / 100 for Sanofi).
  • Segment focus: The Procter & Gamble Company has 5 segments (35.5% in Fabric & Home Care); Sanofi has 3 segments (81.8% in Pharma (Prescription Medicines)).
  • Moat breadth: The Procter & Gamble Company has 2 moat types across 1 domains; Sanofi has 3 across 3.

Primary market context

The Procter & Gamble Company

Fabric & Home Care

Market

Branded fabric care and home care (laundry detergents/additives, dish care, surface/home cleaning, air care)

Geography

Global

Customer

Consumers via retail and e-commerce channels

Role

Brand owner / manufacturer

Revenue share

35.5%

Sanofi

Pharma (Prescription Medicines)

Market

Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)

Geography

Global

Customer

Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)

Role

Research-based drug developer, manufacturer, and marketer

Revenue share

81.8%

Side-by-side metrics

The Procter & Gamble Company
Sanofi
Ticker / Exchange
PG - New York Stock Exchange
SAN - Euronext Paris
Market cap (USD)
$390.8B
$115.7B
Gross margin (TTM)
49.8%
73.4%
Operating margin (TTM)
22.6%
12.7%
Net margin (TTM)
18.2%
8.1%
Sector
Consumer
Healthcare
Industry
Household and personal products
Pharmaceuticals
HQ country
US
FR
Primary segment
Fabric & Home Care
Pharma (Prescription Medicines)
Market structure
Oligopoly
Oligopoly
Market share
35% (reported)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
85 / 100
66 / 100
Moat domains
Demand
Legal, Supply, Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Brand Trust

The Procter & Gamble Company strengths

Installed Base Consumables

Sanofi strengths

IP Choke PointCapex Knowhow Scale

Segment mix

The Procter & Gamble Company segments

Full profile >

Beauty

Oligopoly

18.5%

Grooming

Oligopoly

8%

Health Care

Oligopoly

14.4%

Fabric & Home Care

Oligopoly

35.5%

Baby, Feminine & Family Care

Oligopoly

23.6%

Sanofi segments

Full profile >

Pharma (Prescription Medicines)

Oligopoly

81.8%

Vaccines

Oligopoly

18.2%

Opella (Consumer Healthcare - Sanofi minority stake)

Competitive

0%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.